Kidney function in the very elderly with hypertension: Data from the hypertension in the very elderly (HYVET) trial

Age and Ageing

Volumn 42, Issue 2, 2013, Pages 253-258

  Peters, Ruth ^a   Beckett, Nigel ^a   Poulter, Ruth ^a   Burch, Lisa ^a   Narkiewicz, Krzysztof ^b   Fagard, Robert ^c   Nitsch, Dorothea ^d   Wang, Nan ^a   Li, Mengying ^a   Fletcher, Astrid ^d   Bulpitt, Christopher ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Aged; Antihypertensive; Hypertension; Kidney function; Mortality; Older people.

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN; INDAPAMIDE; PERINDOPRIL; PLACEBO; POTASSIUM; SODIUM; UREA; URIC ACID;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; GERIATRIC CARE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED, 80 AND OVER; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DELAYED-ACTION PREPARATIONS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HYPERTENSION; INDAPAMIDE; KIDNEY; KIDNEY DISEASES; MALE; PERINDOPRIL; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874526805     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs109     Document Type: Article

References (21)

1. Martin J, Sheaff M. Renal ageing. J Pathol. 2007; 211: 198-205.
2. Bulpitt C, Beilin L, Clifton P et al.. Risk factors for death in treated hypertensive patients. Lancet 1979; 2: 134-7.
3. Bulpitt C, Beevers G, Butler A et al.. The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP). J Hypertens. 2986; 4: 93-99.
4. Chronic Kidney Disease Consortium. Association of estimated glomerular filtration rate and albuminuria with all cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073-81.
5. Ruilope L, Zanchetti A, Julius S et al... for the VALUE investigators. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.. J Hypertens. 2007; 25: 1473-9.
6. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J. Association if kidney function and albuminuria with cardiovascular mortality in older vs. younger individuals. Arch Intern Med. 2007; 167: 2490-6.
7. Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW. Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-base cohort study. Nephrol Dial Transplant. 2007; 22: 2586-94.
8. Ingelsson E, Sundström J, Lind L et al... Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J. 2007; 28: 1739-45.
9. Mann J, Gerstein H, Pogue J, Bosch J, Yusuf S. for the HOPE investigators. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001; 134: 629-36.
10. Wachtell K, Ibsen H, Olsen M et al.. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003; 139: 901-6.
11. Solomon S, Lin J, Solomon C et al. for the prevention of events with ACE inhibition (PEACE) investigators. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007; 116: 2687-93.
12. Chamberlain I. Cardiorenal consideration as a risk factor for heart failure. Am J Cardiol. 2007; 99: 21D-4D.
13. Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol. 2007; 22: 1839-48.
14. Brugts J, Boersma E, Chonchol M et al. on behalf of the EUROPA investigators. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency. J Am Coll Cardiol. 2007; 50: 2148-55.
15. Roderick P, Atkins R, Smeeth L et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing. 2008; 37: 179-86.
16. Nitsch D, Nonyane B, Smeeth L, Bulpitt C, Roderick P, Fletcher A. CKD and hospitalisation in the elderly: a community-based cohort study in the United Kingdom. Am J Kidney Dis. 2011; 57: 664-72.
17. Beckett N, Peters R, Fletcher A et al. for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. NEJM. 2008; 358: 1887-98.
18. Bulpitt C, Fletcher A, Beckett N et al. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging. 2001; 18: 151-64.
19. Levey A, Stevens L, Schmid C et al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Int Med. 2009; 150: 604-12.
20. Biörk J, Bäck E, Sterner G et al. Prediction of relative glomerular filtration rate in adults; nre improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest. 2007; 67: 678-95.
21. Stevens L, Claybon M, Schmid C et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kid Int. 2011; 79: 555-62.